292 KB23 KB192920262023Makuc, JanaŠorli, Jurijštevilka:3-4letnik:92str. 149-153COBISSID_HOST:153394179ISSN:1581-0224URN:URN:NBN:SI:doc-D3Z8J8Q0slSlovensko zdravniško društvoZdravniški vestnikepidemicsepidemijeguidelinesinfectionintensive careintenzivna negamortalityokužbesmernicesmrtnostCovid-19: naše izkušnje in analiza kakovosti akutne obravnave| (prikaz primera obravnave Bolnišnice Topolšica)| COVID-19: our experience and quality of management analysis| (Topolšica Hospital case report)|Various Slovenian hospitals were recruited to treat COVID-19 patients in Slovenia during the COVID-19 epidemic. Centrally coordinated hospital utilisation - depending on the needs, available hospital bed capacity, and considering the pro-fessional orientation of individual hospitals - left these facilities with different experiences. We present our experience and COVID-19 treatment management during the fourth epidemic wave in our peripheral, pulmonary-oriented hospital, representing the first treatment quality analysis of these patients in Slovenia. The basic hospitalization characteristics were analysed using integrated Birpis information system solutions and the electronic temperature-therapeutic charts (eTTL) review. The quality of management was assessed through adherence to professional recommendations. The anal-ysis was carried out with the in-built statistical functions of Microsoft Excel software. 99 patients (58 women, 41 men) aged 67.9 years were hospitalised for an average of 8.1 days. The majority were residents of our region (61%), unvaccinated (61.6%), and experienced a severe form of the disease with the need for oxygen supplementation (88.9%). The majority received steroids (73.7%), antibiotics (68.7%) and vitamin D (71.7%), to a lesser extent specific therapy (remdesivir 25.3%, combination casirivimab/imdevimab 2%, tocilizumab 1%). No adverse reactions were noted. 17 people died (total mortal-ity rate 17.2%). There was no infection transmission among the COVID department staff. Results show successful treatment of patients with COVID-19 in Topolsica Hospital. They also suggest the possibility of further improvements, particularly in prescribing antibiotic therapyV času epidemije covida-19 so se v zdravljenje bolnikov s covidom v Sloveniji vključevale različne slovenske bolnišnice. Ob centralno koordiniranem vključevanju – glede na potrebe in zmogljivosti bolnišnice ter ob upoštevanju strokovne usmer-jenosti posameznih bolnišnic – so bile izkušnje ustanov različne. V prispevku prikazujemo izkušnje z obravnavo bolnikov s covidom-19 v obdobju 4. vala epidemije v periferni, pulmološko usmerjeni bolnišnici, kar je prvi prikaz analize kakovosti obravnave teh bolnikov v Sloveniji. Osnovne značilnosti hospitalizacij smo analizirali s pomočjo integriranih rešitev infor-macijskega sistema Birpis in pregleda elektronske temperaturno-terapevtske liste (eTTL). Kakovost strokovne obravnave smo ocenjevali glede na upoštevanje veljavnih strokovnih priporočil. Analiza je potekala z vgrajenimi statističnimi funk-cijami programa Microsoft Excel. 99 bolnikov (58 žensk, 41 moških), starih 67,9 leta, je bilo v povprečju hospitaliziranih 8,1 dneva. Večina so bili prebivalci naše regije (61 %), necepljeni (61,6 %) in s težkim potekom bolezni s potrebo po dodatku kisika (88,9 %). Večina bolnikov je prejela steroide (73,7 %), antibiotik (68,7 %) in vitamin D (71,7 %), v manjši meri so pre-jeli specifično terapijo (remdesivir 25,3 %, kombinacijo kasirivimab/imdevimab 2 %, tocilizumab 1 %). Neželenih učinkov novih zdravil nismo zabeležili. Umrlo je 17 oseb (celokupna smrtnost 17,2 %). Med osebjem na covidnem oddelku ni prišlo do prenosa okužb. Rezultati kažejo, da je bilo zdravljenje bolnikov s covidom-19 v Bolnišnici Topolšica uspešno, hkrati pa nakazujejo možnost dodatnih izboljšav zlasti na področju predpisovanja antibiotikovTEXTznanstveno časopisjejournalsSlovenian National E-content AggregatorNational and University Library of SloveniaSlovensko zdravniško društvo